786 related articles for article (PubMed ID: 7700312)
1. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
Ochs A; Rössle M; Haag K; Hauenstein KH; Deibert P; Siegerstetter V; Huonker M; Langer M; Blum HE
N Engl J Med; 1995 May; 332(18):1192-7. PubMed ID: 7700312
[TBL] [Abstract][Full Text] [Related]
2. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding.
Rössle M; Haag K; Ochs A; Sellinger M; Nöldge G; Perarnau JM; Berger E; Blum U; Gabelmann A; Hauenstein K
N Engl J Med; 1994 Jan; 330(3):165-71. PubMed ID: 8264738
[TBL] [Abstract][Full Text] [Related]
3. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
4. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL
N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872
[TBL] [Abstract][Full Text] [Related]
5. [Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients].
Vandistel G; Nevens F; Stockx L; Raat H; Wilms G; Fevery J
Ned Tijdschr Geneeskd; 1996 Dec; 140(49):2455-8. PubMed ID: 8999346
[TBL] [Abstract][Full Text] [Related]
6. [The transjugular intrahepatic portosystemic stent-shunt (TIPS) in the management of portal hypertension. A preliminary report].
Aguilar Ramírez JR; Alcantara Peraza RA; Hernández Pérez RE; Gómez Maganda y Silva T; Heredia Jarero NM; Torres Valadez F; Gómez del Campo López A
Rev Gastroenterol Mex; 1994; 59(3):218-22. PubMed ID: 7716362
[TBL] [Abstract][Full Text] [Related]
7. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
8. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
[TBL] [Abstract][Full Text] [Related]
9. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt.
Panagiotou I; Kelekis DA; Karatza C; Nikolaou V; Mouyia V; Brountzos EN
Hepatogastroenterology; 2007 Sep; 54(78):1813-6. PubMed ID: 18019724
[TBL] [Abstract][Full Text] [Related]
11. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
Wong W; Liu P; Blendis L; Wong F
Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
[TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy.
Kochar N; Tripathi D; Ireland H; Redhead DN; Hayes PC
Gut; 2006 Nov; 55(11):1617-23. PubMed ID: 16571635
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation.
Attwell A; Ludkowski M; Nash R; Kugelmas M
Aliment Pharmacol Ther; 2004 Oct; 20(8):867-73. PubMed ID: 15479358
[TBL] [Abstract][Full Text] [Related]
14. [Experience with the transjugular intrahepatic portocaval shunt].
Dagenais M; Pomier Layrargues G; Dufresne MP; Roy A; Fenyves D; Lapointe R
Ann Chir; 1994; 48(8):671-8. PubMed ID: 7872613
[TBL] [Abstract][Full Text] [Related]
15. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
Orloff MJ; Orloff MS; Orloff SL; Girard B
J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
[TBL] [Abstract][Full Text] [Related]
16. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
17. Intravascular ultrasound-guided direct intrahepatic portacaval shunt: description of technique and technical refinements.
Petersen B
J Vasc Interv Radiol; 2003 Jan; 14(1):21-32. PubMed ID: 12525583
[TBL] [Abstract][Full Text] [Related]
18. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.
Nair S; Singh R; Yoselewitz M
J Vasc Interv Radiol; 2004 Dec; 15(12):1431-4. PubMed ID: 15590801
[TBL] [Abstract][Full Text] [Related]
19. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
20. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt.
Russo MW; Jacques PF; Mauro M; Odell P; Brown RS
Liver Transpl; 2002 Mar; 8(3):271-7. PubMed ID: 11910573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]